Not all individuals with CLL require therapy. Irrespective of all latest developments, the iwCLL however recommends watchful observation for patients with asymptomatic disease.86 This advice is predicated on no less than two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both equally trials conc... https://mikhailx975wfm3.tusblogos.com/profile